Egetis Therapeutics AB Revenue and Competitors
Estimated Revenue & Valuation
- Egetis Therapeutics AB's estimated annual revenue is currently $10.5M per year.
- Egetis Therapeutics AB's estimated revenue per employee is $201,000
Employee Data
- Egetis Therapeutics AB has 52 Employees.
- Egetis Therapeutics AB grew their employee count by 8% last year.
Egetis Therapeutics AB's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Consultant - VP Medical Affairs | Reveal Email/Phone |
2 | CEO and President | Reveal Email/Phone |
3 | Head Accounting | Reveal Email/Phone |
4 | Head Investor Relations and Communication | Reveal Email/Phone |
5 | VP, Market Access & Pricing - North America | Reveal Email/Phone |
6 | VP Commercial Operations | Reveal Email/Phone |
7 | Head CMC | Reveal Email/Phone |
8 | VP Product Strategy and Development | Reveal Email/Phone |
9 | Chief Scientific Officer at Egetis Therapeutics AB | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
Egetis Therapeutics AB Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Egetis Therapeutics AB?
N/A
Total Funding
52
Number of Employees
$10.5M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Egetis Therapeutics AB News
2022-04-19 - Egetis Therapeutics publishes prospectus relating to the Rights Issue
Pareto Securities AB acts as Sole Manager and Bookrunner in connection with the Rights Issue. Advokatfirman Lindahl KB acts as legal adviser to...
2022-04-13 - Egetis Therapeutics' 2021 annual report published
Stockholm, Sweden , April 20, 2022 Egetis Therapeutics AB (publ) (Egetis or the Company) (Nasdaq Stockholm: EGTX) Annual Report for...
2022-03-30 - Egetis announces that the recruitment target has been met in the Emcitate®
Triac Trial II study
Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today announced that the recruitment target of 16 patients has been met in the Triac...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.6M | 52 | -5% | N/A |
#2 | $7M | 52 | 8% | N/A |
#3 | $7M | 52 | 8% | N/A |
#4 | $4.7M | 52 | -12% | N/A |
#5 | $3.5M | 52 | -9% | N/A |